AAAAAA
Results:
1-8
|
Results: 8
Authors:
Wizemann, V
Kulz, M
Techert, F
Nederlof, B
Citation: V. Wizemann et al., Efficacy of haemodiafiltration, NEPH DIAL T, 16, 2001, pp. 27-30
Authors:
Canaud, B
Wizemann, V
Pizzarelli, F
Greenwood, R
Schultze, G
Weber, C
Falkenhagen, D
Citation: B. Canaud et al., Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy, NEPH DIAL T, 16(11), 2001, pp. 2181-2187
Authors:
Wizemann, V
Citation: V. Wizemann, Regular dialysis treatment in Germany: the role of non-profit organisations, J NEPHROL, 13, 2000, pp. S16-S19
Authors:
Wizemann, V
Citation: V. Wizemann, International Symposium on Haemodiafiltration - 11 October, 1997 - Giessen/Bad Nauheim, Germany - Forward, NEPH DIAL T, 15, 2000, pp. 1-1
Authors:
Wizemann, V
Lotz, C
Techert, F
Uthoff, S
Citation: V. Wizemann et al., On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study, NEPH DIAL T, 15, 2000, pp. 43-48
Authors:
Wizemann, V
Citation: V. Wizemann, How to dialyse the patient with coronary artery disease and cardiac failure?, NIEREN HOCH, 29(10), 2000, pp. 507-512
Authors:
Santoro, A
Panzetta, G
Tessitore, N
Atti, M
Mancini, E
Esteban, J
London, G
Ara, JM
Miguel, JL
Neumann, KH
Opatrny, K
Perez, R
Perrone, B
Wizemann, V
Zucchelli, P
Citation: A. Santoro et al., A prospective randomised European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis, J NEPHROL, 12(6), 1999, pp. 375-382
Authors:
Wizemann, V
Citation: V. Wizemann, Quality criteria in the treatment of dialysis patients with cardiovascularco-morbidity, NIEREN HOCH, 28(1), 1999, pp. 7-10
Risultati:
1-8
|